Hosted by the New Jersey Academic Drug Discovery Consortium, the Translational Neuroscience Event will feature two panel sessions to discuss "Advances in the Treatment of Alzheimer's Disease" and "CNS Models and Biomarkers."
Session 1: Advances in the Treatment of Alzheimer's Disease
Samuel Gandy, Mount Sinai Professor of Alzheimer's Disease Research
Moderator: Mark Day, Adjunct Associate Professor, Neuroscience, Yale University
Session 2: CNS Models & Biomarkers
|Keynote Speaker||Mark Varney, Chief Scientific Officer, PsychoGenics|
Moderator: Sam Kongsamut, Co-founder, Vice President Research & Development, Bryologyx and Strategic Advisor, ILSE
Brought to you by: Institute for Life Science Entrepreneurship; Rutgers University; Stevens Institute of Technology; Princeton University; Rowan University